They are some of the brightest, loudest, oddest-looking, least-understood birds on the planet, and thanks to a comprehensive new evolutionary 'tree of life' generated for the tropical cotinga family ...
LONDON, ONTARIO and BOSTON, MASSACHUSETTS--(Marketwired - Jan 25, 2018) - Cotinga Pharmaceuticals Inc. (formerly Critical Outcome Technologies Inc.) (TSX VENTURE:COT ...
LONDON, Ontario and BOSTON, July 02, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company ...
TORONTO and BOSTON, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline of ...
LONDON, ONTARIO and BOSTON, MASSACHUSETTS--(Marketwired - Jan 8, 2018) - Critical Outcome Technologies Inc. (TSX VENTURE:COT)(COTQF) ("COTI" or the "Company"), a clinical-stage pharmaceutical company ...
* COTINGA PHARMACEUTICALS - SUBMITTED AN UPDATED CLINICAL PACKAGE TO REGULATORY AUTHORITIES TO EXPAND ITS ONGOING PHASE 1 TRIAL OF COTI-2 * COTINGA PHARMACEUTICALS - PROTOCOL AMENDMENT WILL EXPAND ...
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company’s lead compound is COTI-2, an oral ...
TORONTO and BOSTON, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline of ...